Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is 183.78% as of the fiscal period ended Tuesday, June 30, 2026.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
Limited quarterly history available
ROE needs at least three reported quarters before a meaningful chart is shown.
RETURN ON EQUITY (ROE)
183.78%
RETURN ON EQUITY (ROE) AVG TTM
N/A
RETURN ON EQUITY (ROE) AVG 3Y
N/A
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · FINANCIAL SERVICES
8.76%
median of 677 covered companies
CURRENT VS SECTOR MEDIAN
+1997.98%
vs the sector median at left
Soren Acquisition Corp.
Market Cap
$263.53M
Return on Equity (ROE)
183.78%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.38M
Return on Equity (ROE)
4.42%
TTM Avg
99.43%
3Y Avg
99.43%
5Y Avg
99.43%
Market Cap
$264.47M
Return on Equity (ROE)
3.49%
TTM Avg
2.30%
3Y Avg
2.30%
5Y Avg
2.30%
Market Cap
$264.76M
Return on Equity (ROE)
3.41%
TTM Avg
1.87%
3Y Avg
1.87%
5Y Avg
1.87%
Market Cap
$261.73M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.45M
Return on Equity (ROE)
1.17%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$261.39M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.27M
Return on Equity (ROE)
2.18%
TTM Avg
0.24%
3Y Avg
0.16%
5Y Avg
0.16%
Market Cap
$261.25M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Soren Acquisition Corp. (SORN) | $263.53M | 183.78% | N/A | N/A | N/A |
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)vs › | $264.38M | 4.42% | 99.43% | 99.43% | 99.43% |
| ProCap Acquisition Corp (PCAP)vs › | $264.47M | 3.49% | 2.30% | 2.30% | 2.30% |
| Oaktree Acquisition Corp. II (OACC)vs › | $264.76M | 3.41% | 1.87% | 1.87% | 1.87% |
| AMR Resources Acquisition Corp Class A Ordinary Shares (AMAC)vs › | $261.73M | N/A | N/A | N/A | N/A |
| GigCapital8 Corp. (GIW)vs › | $261.45M | 1.17% | 0.00% | 0.00% | 0.00% |
| Mountain Lake Acquisition Corp. II Class A Ordinary Shares (MLAA)vs › | $261.39M | N/A | N/A | N/A | N/A |
| Cantor Equity Partners V, Inc. Class A Ordinary Shares (CEPV)vs › | $261.27M | 2.18% | 0.24% | 0.16% | 0.16% |
| Art Technology Acquisition Corp. (ARTC)vs › | $261.25M | N/A | N/A | N/A | N/A |
| Thunder Bridge Capital Partners V L (TBCVU)vs › | $266.29M | N/A | N/A | N/A | N/A |
ROE
183.8%
ROA
1.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 183.78% |
